A randomized Phase II trial of TG4001 + avelumab versus avelumab alone in patients with HPV-positive anogenital cancers
Latest Information Update: 13 Nov 2023
At a glance
- Drugs Tipapkinogene sovacivec (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 07 Nov 2023 According to a Transgene media release, data readout expected in 2024.
- 16 Mar 2022 According to a Transgene media release, company expects to report the results of this analysis in the fourth quarter of 2022.
- 24 Jun 2021 According to a Transgene media release, patients with liver metastases will be followed in an ancillary arm and will not be included in the primary analyses.